Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age
Keywords: کارسینوامبریونیک آنتی ژن; HE4; CA-125; CEA; Adnexal mass; Ovarian cancer;